QL
AUPH icon

Quarry LP’s Aurinia Pharmaceuticals AUPH Stock Holding History

Quarry LP’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,000
Closed -$80.4K – 1729
2025
Q1 		$80.4K Sell
10,000
-2,000
-17% -$16.2K 0.02% 606
2024
Q4 		$108K Buy
+12,000
New +$97.9K 0.02% 413

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Quarry LP's AUPH Position: Q2 2025 in Review

Quarry LP sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2025, closing a stake of 10,000 shares — an estimated $80.4K sold.

Quarry LP first reported a position in AUPH in Q4 2024 and held it in 2 quarters. The position peaked at $108K in Q4 2024. 219 funds tracked by Wall St. Rank hold AUPH as of Q2 2025.

  • Quarry LP reported no remaining Aurinia Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Quarry LP sold 10,000 Aurinia Pharmaceuticals shares in Q2 2025, an estimated $80.4K.
  • Quarry LP first reported a position in Aurinia Pharmaceuticals in Q4 2024 and held it in 2 quarters.
  • Quarry LP's Aurinia Pharmaceuticals position peaked at $108K in Q4 2024.
  • 219 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2025.

Based on Quarry LP's 13F filing for Q2 2025, filed 14 Aug 2025.